Aerovate Therapeutics
AVTE
#8981
Rank
C$82.81 M
Marketcap
$2.87
Share price
1.20%
Change (1 day)
-84.10%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$23.46 M

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are C$23.46 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$11.61 M211.57%
2021-12-31C$3.72 M-83.82%
2020-12-31C$23.02 M148.21%
2019-12-31C$9.27 M